Astatine Radiopharmaceuticals: Prospects and Problems.

@article{Vaidyanathan2008AstatineRP,
  title={Astatine Radiopharmaceuticals: Prospects and Problems.},
  author={Ganesan Vaidyanathan and Michael R. Zalutsky},
  journal={Current radiopharmaceuticals},
  year={2008},
  volume={1 3},
  pages={177}
}
For the treatment of minimum residual diseases such micrometastases and residual tumor margins that remain after debulking of the primary tumor, targeted radiotherapy using radiopharmaceuticals tagged with alpha-particle-emitting radionuclides is very attractive. In addition to the their short range in tissue, which helps minimize harmful effects on adjacent normal tissues, alpha-particles, being high LET radiation, have several radiobiological advantages. The heavy halogen, astatine-211 is one… CONTINUE READING

From This Paper

Topics from this paper.
13 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

Similar Papers

Loading similar papers…